SK pharmteco doubles viral vector production capacity in Europe ...Middle East

News by : (PR Newswire) -
Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes its second bioproduction facility and doubles its manufacturing footprint to 10,000m2, one of the largest in Europe Operation of the second facility to kick...

Hence then, the article about sk pharmteco doubles viral vector production capacity in europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SK pharmteco doubles viral vector production capacity in Europe )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار